169 related articles for article (PubMed ID: 26496938)
21. Nerve growth factor downregulates inflammatory response in human monocytes through TrkA.
Prencipe G; Minnone G; Strippoli R; De Pasquale L; Petrini S; Caiello I; Manni L; De Benedetti F; Bracci-Laudiero L
J Immunol; 2014 Apr; 192(7):3345-54. PubMed ID: 24585880
[TBL] [Abstract][Full Text] [Related]
22. Cell-cycle arrest in TrkA-expressing NIH3T3 cells involves nitric oxide synthase.
Bulseco DA; Poluha W; Schonhoff CM; Daou MC; Condon PJ; Ross AH
J Cell Biochem; 2001; 81(1):193-204. PubMed ID: 11180409
[TBL] [Abstract][Full Text] [Related]
23. The leukemia inhibitory factor (LIF) and p21 mediate the TGFβ tumor suppressive effects in human cutaneous melanoma.
Humbert L; Ghozlan M; Canaff L; Tian J; Lebrun JJ
BMC Cancer; 2015 Mar; 15():200. PubMed ID: 25885043
[TBL] [Abstract][Full Text] [Related]
24. Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines.
Tanami H; Imoto I; Hirasawa A; Yuki Y; Sonoda I; Inoue J; Yasui K; Misawa-Furihata A; Kawakami Y; Inazawa J
Oncogene; 2004 Nov; 23(54):8796-804. PubMed ID: 15467732
[TBL] [Abstract][Full Text] [Related]
25. MAP kinase activity supported by BRAF (V600E) mutation rather than gene amplification is associated with ETV1 expression in melanoma brain metastases.
Birner P; Berghoff AS; Dinhof C; Pirker C; Capper D; Schoppmann SF; Petzelbauer P; von Deimling A; Berger W; Preusser M
Arch Dermatol Res; 2014 Dec; 306(10):873-84. PubMed ID: 25073704
[TBL] [Abstract][Full Text] [Related]
26. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.
Davidson B; Lazarovici P; Ezersky A; Nesland JM; Berner A; Risberg B; Tropé CG; Kristensen GB; Goscinski M; van de Putte G; Reich R
Clin Cancer Res; 2001 Nov; 7(11):3457-64. PubMed ID: 11705863
[TBL] [Abstract][Full Text] [Related]
27. Direct effects of nerve growth factor on thecal cells from antral ovarian follicles.
Dissen GA; Parrott JA; Skinner MK; Hill DF; Costa ME; Ojeda SR
Endocrinology; 2000 Dec; 141(12):4736-50. PubMed ID: 11108289
[TBL] [Abstract][Full Text] [Related]
28. p53 is required for nerve growth factor-mediated differentiation of PC12 cells via regulation of TrkA levels.
Zhang J; Yan W; Chen X
Cell Death Differ; 2006 Dec; 13(12):2118-28. PubMed ID: 16729028
[TBL] [Abstract][Full Text] [Related]
29. Amplification of fibroblast growth factor receptor-1 in breast cancer and the effects of brivanib alaninate.
Shiang CY; Qi Y; Wang B; Lazar V; Wang J; Fraser Symmans W; Hortobagyi GN; Andre F; Pusztai L
Breast Cancer Res Treat; 2010 Oct; 123(3):747-55. PubMed ID: 20024612
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of PLC-gamma1 activity converts nerve growth factor from an anti-mitogenic to a mitogenic signal in CHO cells.
Zapf-Colby A; Eichhorn J; Webster NJ; Olefsky JM
Oncogene; 1999 Sep; 18(35):4908-19. PubMed ID: 10490825
[TBL] [Abstract][Full Text] [Related]
31. Signaling networks in cutaneous melanoma metastasis identified by complementary DNA microarrays.
Nambiar S; Mirmohammadsadegh A; Doroudi R; Gustrau A; Marini A; Roeder G; Ruzicka T; Hengge UR
Arch Dermatol; 2005 Feb; 141(2):165-73. PubMed ID: 15724012
[TBL] [Abstract][Full Text] [Related]
32. TRAF4-mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis.
Singh R; Karri D; Shen H; Shao J; Dasgupta S; Huang S; Edwards DP; Ittmann MM; O'Malley BW; Yi P
J Clin Invest; 2018 Jul; 128(7):3129-3143. PubMed ID: 29715200
[TBL] [Abstract][Full Text] [Related]
33. TrkA signalling pathways in human airway smooth muscle cell proliferation.
Freund-Michel V; Bertrand C; Frossard N
Cell Signal; 2006 May; 18(5):621-7. PubMed ID: 16091303
[TBL] [Abstract][Full Text] [Related]
34. Constitutively active Src facilitates NGF-induced phosphorylation of TrkA and causes enhancement of the MAPK signaling in SK-N-MC cells.
Tsuruda A; Suzuki S; Maekawa T; Oka S
FEBS Lett; 2004 Feb; 560(1-3):215-20. PubMed ID: 14988025
[TBL] [Abstract][Full Text] [Related]
35. Nerve growth factor stimulates clonal growth of human lung cancer cell lines and a human glioblastoma cell line expressing high-affinity nerve growth factor binding sites involving tyrosine kinase signaling.
Oelmann E; Sreter L; Schuller I; Serve H; Koenigsmann M; Wiedenmann B; Oberberg D; Reufi B; Thiel E; Berdel WE
Cancer Res; 1995 May; 55(10):2212-9. PubMed ID: 7538048
[TBL] [Abstract][Full Text] [Related]
36. NGF-induced TrkA/CD44 association is involved in tumor aggressiveness and resistance to lestaurtinib.
Aubert L; Guilbert M; Corbet C; Génot E; Adriaenssens E; Chassat T; Bertucci F; Daubon T; Magné N; Le Bourhis X; Toillon RA
Oncotarget; 2015; 6(12):9807-19. PubMed ID: 25840418
[TBL] [Abstract][Full Text] [Related]
37. Transdifferentiation effects and related mechanisms of nerve growth factor and internal limiting membrane on Müller cells.
Zhang L; Li X; Shen Y; Lin X; Wu M
Exp Eye Res; 2019 Mar; 180():146-154. PubMed ID: 30578789
[TBL] [Abstract][Full Text] [Related]
38. NGF and ProNGF: Regulation of neuronal and neoplastic responses through receptor signaling.
Bradshaw RA; Pundavela J; Biarc J; Chalkley RJ; Burlingame AL; Hondermarck H
Adv Biol Regul; 2015 May; 58():16-27. PubMed ID: 25491371
[TBL] [Abstract][Full Text] [Related]
39. Quercetin reverses experimental pulmonary arterial hypertension by modulating the TrkA pathway.
He Y; Cao X; Liu X; Li X; Xu Y; Liu J; Shi J
Exp Cell Res; 2015 Nov; 339(1):122-34. PubMed ID: 26476374
[TBL] [Abstract][Full Text] [Related]
40. Regulation of NGF responsiveness in human neuroblastoma.
Bogenmann E; Peterson S; Maekawa K; Matsushima H
Oncogene; 1998 Nov; 17(18):2367-76. PubMed ID: 9811468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
